title: Worsening psoriasis after treatment with G-CSF in a patient with small-cell lung cancer.
authors.forename: J
authors.initials: J
authors.lastname: Feliu
authors.forename: R
authors.initials: R
authors.lastname: Díaz
authors.forename: F
authors.initials: F
authors.lastname: Contreras
authors.forename: M
authors.initials: M
authors.lastname: Casado
authors.forename: E
authors.initials: E
authors.lastname: Espinosa
authors.forename: M G
authors.initials: MG
authors.lastname: Barón
mesh_terms: D000208:Acute Disease; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D018288:Carcinoma, Small Cell / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D002908:Chronic Disease; D018450:Disease Progression; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects* / Q000276:immunology; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced / Q000188:drug therapy; D011565:Psoriasis / Q000139:chemically induced* / Q000150:complications / Q000276:immunology
chemical_list: D016179:Granulocyte Colony-Stimulating Factor